TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›ATLO
ATLO logo

ATLO

AMES NATIONAL CORP

Next earnings Jul 16, 2026 · consensus $0.67 EPS

Last earnings -0.4% on 2026-04-24

Hold
$29.53
▼ -1.11%
$29.53▲ +74.79%
over 1Y
L $16.89H $30.85
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-1.1%
1W-2.4%
1M+1.6%
3M+5.0%
YTD+32.1%
1Y+74.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
A-
Valuation
Undervalued
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 6 analysts
Sell

Cheap Iowa community bank staging a real NIM-driven earnings recovery, but flat balance sheet and volatile history cap it at a hold.

Net income $19.0M · FY2025

The read

Middling fundamentals offset by an attractive price (~237% below fair value) — worth a look on the value angle.

Ames National is a small-cap multi-bank holding company in Iowa whose FY2025 story is a margin-led recovery, not a growth breakout. Net income jumped 86.2% to $19.0M, but the MD&A shows the driver plainly: net interest income rose to $55.7M from $45.0M as interest expense fell to $31.4M (from $37.6M) while interest income climbed to $87.1M. Net interest margin expanded to 2.75% from 2.22%, and the efficiency ratio improved sharply to 62.74% from 76.59%. This is a bank earning its way back after two weak years ($10.8M in 2023, $10.2M in 2024) — the five-year net-income line ($23.9M→$19.3M→$10.8M→$10.2M→$19.0M) still sits below its 2021 peak, so 2025 is best read as normalization rather than a new plateau.

Quality and capital are solid. The equity-to-assets ratio rose to 9.74% (from 8.19%), stockholders' equity grew 19% to $208M, ROE recovered to ~9.95% (MD&A) and credit costs stayed benign at a $1.0M loss expense. Management also cut the dividend payout to 28% (dividends paid down 21.7% to $7.1M), retaining capital and lifting buybacks — a defensible move that shores up the balance sheet. Long-term debt is trivial ($18.4M) and cash grew 25% to $127M. On valuation the stock trades around 1.26x book ($261M market cap vs $208M equity) with a 2.61% yield — inexpensive, but not a screaming bargain for a bank running sub-10% ROE.

Is ATLO a buy? The one-page verdict, explained →

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—————
Gross profit—————
Operating income—————
Net income$23.9M$19.3M$10.8M$10.2M$19.0M
Diluted EPS$2.62————
Net margin—————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF12.6
PEG (trailing)0.13
Earnings yield7.3%
FCF yield7.9%

Quality & risk

ROIC (est.)—
Free cash flow$20.7M
Total debt$18.4M
Net cash$108M
Piotroski F-Score6/6

Capital returns

Buyback yield0.6%
Dividend yield (est.)2.7%
Shareholder yield3.4%
Shares Δ YoY-0.7%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Other event2026-05-15

    Item 8.01 other-event release with exhibit; routine corporate/dividend-type disclosure

  2. 10-Q Quarterly report2026-05-08

    Q1 2026: earnings momentum intact as NIM expands off repricing tailwind

  3. 8-K Shareholder vote2026-05-01

    Item 5.07: annual-meeting voting results reported; no financial impact

  4. 8-K Earnings results2026-04-24

    Q1 2026 earnings released; continues NIM-driven recovery from FY2025

  5. DEF 14A Proxy statement2026-03-13

    Annual proxy: board, pay and auditor for shareholder vote; no financial change

  6. 10-K Annual report2026-03-12

    FY2025: net income +86%, NIM 2.75% vs 2.22%, efficiency ratio to 62.7%

  7. 8-K Reg FD disclosure2026-02-13

    Reg FD / other-event release with exhibit; routine dividend/PR-type disclosure

  8. 8-K Earnings results2026-01-23

    FY2025 results announced: net income $19.0M, up 86% YoY

  9. 8-K Other event2025-11-13

    Item 8.01 other-event release with exhibit; routine dividend/PR disclosure

Recent filings

all on EDGAR ↗
11-KPeriod ending 2025-12-312026-06-24open ↗4Period ending 2026-05-292026-05-29open ↗SCHEDULE 13GFiling2026-05-15open ↗8-KPeriod ending 2026-05-132026-05-15open ↗4Period ending 2026-05-152026-05-15open ↗13F-HRPeriod ending 2026-03-312026-05-12open ↗4Period ending 2026-05-122026-05-12open ↗10-QPeriod ending 2026-03-312026-05-08open ↗3Period ending 2026-04-302026-05-04open ↗8-KPeriod ending 2026-04-292026-05-01open ↗4Period ending 2026-04-302026-04-30open ↗4Period ending 2026-04-302026-04-30open ↗

Quality score

A-
ValueGrowthProfitHealthMom.
ValueA
GrowthA+
ProfitabilityB-
Financial healthA-
MomentumA-
  • ✓Profitable (positive net income)
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$99.56

Undervalued +237% vs price

cheapfair valueexpensive

Modified Graham: EPS $2.62 × (8.5 + 1.5 × 22.0% growth) × 1.00 quality = 38.0× multiple. An estimate, not a price target.

17.3652-week30.85
Revenue
—
Net margin
—
ROE
9.2%
P/E
11.3

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Net income$19.0M+86.2%
Diluted EPS$2.62+27.2%
Cash & equivalents$127M+25.2%
Total assets$2.13B+0.0%
Total liabilities$1.93B-1.7%
Stockholders' equity$208M+19.0%
L/E: 9.26x

Frequently asked

Is AMES NATIONAL CORP (ATLO) a buy?
ATLO currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Cheap Iowa community bank staging a real NIM-driven earnings recovery, but flat balance sheet and volatile history cap it at a hold.
What is ATLO's fair value?
A Modified-Graham model based on ATLO's SEC fundamentals estimates a fair value of about $99.56. It is an estimate from reported earnings, not a price target.
Is ATLO overvalued or undervalued?
Against a Modified-Graham fair-value estimate, ATLO currently appears undervalued relative to its SEC-grounded earnings power.
What is AMES NATIONAL CORP's quality score?
ATLO scores 80.95702710129919/100 (grade A-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001132651, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 7/3/2026, 10:44:30 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 6:44 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 4 open-market buys · 0 sales

2026-05-29
Cassabaum Michelle R
Director
Buy170.00 @ $28.83$4.90K
2026-05-15
Hagan Patrick G
Director
Buy200.00 @ $27.69$5.54K
2026-05-12
Hagan Patrick G
Director
Buy100.00 @ $27.65$2.77K
2026-04-30
Cassabaum Michelle R
Director
Buy84.00 @ $28.08$2.36K
2026-02-27
Cassabaum Michelle R
Director
Buy205.00 @ $27.25$5.59K
2026-01-30
Cassabaum Michelle R
Director
Buy280.00 @ $26.11$7.31K

Dividends

Quarterly
Yield (TTM)
3.0%
Annual / share
$0.88
Last ex-date
2026-06-01
Last amount
$0.24
ex 2026-06-01paid 2026-06-15$0.24
ex 2026-02-27paid 2026-03-13$0.24
ex 2025-12-01paid 2025-12-15$0.20
ex 2025-08-29paid 2025-09-15$0.20
ex 2025-05-30paid 2025-06-13$0.20
ex 2025-01-31paid 2025-02-14$0.20

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-24Beat +5.9% est▼ -0.43%8-K ↗
2026-01-23—▼ -0.82%8-K ↗
2025-10-17—▼ -0.36%8-K ↗
2025-07-18—▼ -0.61%8-K ↗
2025-04-17—▲ +0.54%8-K ↗
2025-01-24—▲ +0.68%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score81 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity9.2% vs 12.0%
P/E11.3 vs 26.2